The anti-atherosclerotic action of SAMB may also be attributed to its inhibitory role on endothelial dysfunction, which was possibly supported by the suppressive impact of SAMB on VCAM-1 expression in endothelial cells42. The gene discussed is VCAM1; the disease is endothelial dysfunction.